Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.925 SEK | +1.09% | -9.14% | +34.25% |
Sales 2024 * | 266M 24.32M 2.03B | Sales 2025 * | 136M 12.4M 1.03B | Capitalization | 701M 64.09M 5.34B |
---|---|---|---|---|---|
Net income 2024 * | - 0 0 | Net income 2025 * | -72M -6.58M -549M | EV / Sales 2024 * | 1.52 x |
Net cash position 2024 * | 298M 27.21M 2.27B | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 5.17 x |
P/E ratio 2024 * |
-1.74
x | P/E ratio 2025 * |
-2.91
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.47% |
Latest transcript on Alligator Bioscience AB
1 day | +1.09% | ||
1 week | -9.14% | ||
Current month | -6.94% | ||
1 month | -5.80% | ||
3 months | -23.81% | ||
6 months | +143.42% | ||
Current year | +34.25% |
Managers | Title | Age | Since |
---|---|---|---|
Søren Bregenholt
CEO | Chief Executive Officer | 53 | 01/21/01 |
Marie Svensson
DFI | Director of Finance/CFO | 60 | 01/20/01 |
Chief Tech/Sci/R&D Officer | 56 | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Graham Dixon
BRD | Director/Board Member | 63 | 09/19/09 |
Chairman | 70 | 01/17/01 | |
Staffan Encrantz
BRD | Director/Board Member | 73 | 09/22/09 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.925 | +1.09% | 808,960 |
25/24/25 | 0.915 | -0.54% | 1,694,028 |
24/24/24 | 0.92 | -6.50% | 2,734,872 |
23/24/23 | 0.984 | -1.01% | 963,340 |
22/24/22 | 0.994 | -2.36% | 786,608 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 08:59 pm IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.25% | 63.95M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ATORX Stock